Citadel Advisors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$9,017,000
-80.8%
132,397
-91.0%
0.00%
-81.8%
Q2 2022$46,920,000
-35.2%
1,468,554
-29.7%
0.01%
-26.7%
Q1 2022$72,384,000
+33.4%
2,089,632
+12.8%
0.02%
+36.4%
Q4 2021$54,242,000
+1026.1%
1,853,156
+880.4%
0.01%
Q3 2021$4,817,000
-18.5%
189,029
+12.0%
0.00%
-100.0%
Q2 2021$5,911,000
-88.5%
168,800
-86.7%
0.00%
-92.3%
Q1 2021$51,559,000
+96.1%
1,265,253
+108.4%
0.01%
+85.7%
Q4 2020$26,292,000
-42.3%
607,045
-26.5%
0.01%
-46.2%
Q3 2020$45,550,000
+56.6%
826,072
+79.3%
0.01%
+18.2%
Q2 2020$29,088,000
+70.7%
460,765
+38.1%
0.01%
+57.1%
Q1 2020$17,044,000
-74.3%
333,594
-60.0%
0.01%
-75.9%
Q4 2019$66,282,000
+323.2%
833,850
+158.3%
0.03%
+314.3%
Q3 2019$15,663,000
-51.9%
322,809
-47.9%
0.01%
-50.0%
Q2 2019$32,570,000
+77.2%
619,207
+78.3%
0.01%
+55.6%
Q1 2019$18,382,000
+136.8%
347,305
+83.6%
0.01%
+80.0%
Q4 2018$7,763,000
+0.5%
189,122
-7.0%
0.01%
+66.7%
Q3 2018$7,723,000
-51.7%
203,251
-42.6%
0.00%
-62.5%
Q2 2018$15,993,000
+99.2%
353,832
+112.9%
0.01%
+100.0%
Q1 2018$8,029,000
-71.5%
166,210
-76.8%
0.00%
-76.5%
Q4 2017$28,199,000
+231.7%
716,611
+161.7%
0.02%
+183.3%
Q3 2017$8,501,000
-79.4%
273,783
-81.9%
0.01%
-82.4%
Q2 2017$41,308,000
+24.0%
1,510,335
+67.1%
0.03%
+13.3%
Q1 2017$33,309,000
+4805.6%
903,952
+1825.9%
0.03%
Q4 2016$679,000
-47.4%
46,936
-16.2%
0.00%
-100.0%
Q3 2016$1,291,00056,0270.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders